BridgeMD
New treatment option for PTSD
Official title Integrated PTSD and Chronic Pain Treatment
ClinicalTrials.gov ID: NCT07225049
What this study is testing
- What it's testing
- Posttraumatic stress disorder (PTSD) occurs in approximately 7% of adults in the general population. PTSD greatly impacts quality of life and often co-occurs with other conditions such as chronic pain.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years or older
- English-speaking
- Currently meets criteria for PTSD, assessed by the CAPS-5 (any trauma type) - Chronic pain, assessed by greater than or equal to 4 on a scale of 0-10...
- Medically stable at the time of study enrollment (chronic illness and disability does not prevent attendance of outpatient therapy sessions)
- Stable on psychotropic medication for past 60 days
You likely can't join if
- Lifetime diagnosis of schizophrenia, other psychotic disorder, or bipolar I disorder
- Participation in concurrent evidence-based psychological treatment for PTSD or chronic pain during the past 3 months
- Participants must not participate in an evidence-based psychological treatment for either PTSD or pain during the course of the study.
- Moderate or severe substance use in the past 90 days
- Cognitive impairment to the degree that the patient cannot provide informed consent or fill out assessment measures
- Participants who in the PI's judgement pose a current homicidal or suicidal risk
See the full eligibility criteria
- 18 years or older
- English-speaking
- Currently meets criteria for PTSD, assessed by the CAPS-5 (any trauma type) - Chronic pain, assessed by greater than or equal to 4 on a scale of 0-10 pain severity over the past 3 months
- Medically stable at the time of study enrollment (chronic illness and disability does not prevent attendance of outpatient therapy sessions)
- Stable on psychotropic medication for past 60 days
- Agreed to not change current medication or pain-related treatments over the course of the study unless medically necessary
- Must be located in the state of New York for virtual assessments and treatment sessions
- Lifetime diagnosis of schizophrenia, other psychotic disorder, or bipolar I disorder
- Participation in concurrent evidence-based psychological treatment for PTSD or chronic pain during the past 3 months
- Participants must not participate in an evidence-based psychological treatment for either PTSD or pain during the course of the study.
- Moderate or severe substance use in the past 90 days
- Cognitive impairment to the degree that the patient cannot provide informed consent or fill out assessment measures
- Participants who in the PI's judgement pose a current homicidal or suicidal risk
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.